Song J, Xu Z, Xie L, Shen J
Pharmaceutics. 2025; 17(2).
PMID: 40006623
PMC: 11858820.
DOI: 10.3390/pharmaceutics17020256.
Khalid Salah Al-Sheakly B, Saheb Sharif-Askari F, Sharif-Askari N, Zakri A, Mdkhana B, Wed Abdelaziz Eladham M
Inflamm Res. 2025; 74(1):43.
PMID: 39969581
DOI: 10.1007/s00011-024-01991-5.
Maisto N, Mango D
J Pharm Anal. 2025; 14(12):101057.
PMID: 39802402
PMC: 11718335.
DOI: 10.1016/j.jpha.2024.101057.
Lee D, Shen A, Shah M, Garbuzenko O, Minko T
Int J Mol Sci. 2024; 25(19).
PMID: 39408684
PMC: 11476875.
DOI: 10.3390/ijms251910357.
Nayak U, Halagali P, Panchal K, Panchal K, Tippavajhala V, Tippavajhala V
Curr Pharm Des. 2024; 31(6):443-460.
PMID: 39318210
DOI: 10.2174/0113816128328722240828184410.
Liposomal Formulations of Anti-Alzheimer Drugs and siRNA for Nose-to-Brain Delivery: Design, Safety and Efficacy In Vitro.
Lee D, Shen A, Garbuzenko O, Minko T
AAPS J. 2024; 26(5):99.
PMID: 39231845
DOI: 10.1208/s12248-024-00967-x.
Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases.
Bozza A, Bordano V, Marengo A, Muntoni E, Marini E, Lazzarato L
Pharmaceutics. 2024; 16(8).
PMID: 39204396
PMC: 11360092.
DOI: 10.3390/pharmaceutics16081051.
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays.
Patterlini V, Guareschi F, DAngelo D, Baldini S, Meto S, Mostafa Kamal D
Pharmaceutics. 2024; 16(8).
PMID: 39204334
PMC: 11357686.
DOI: 10.3390/pharmaceutics16080989.
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges.
Bai Z, Wan D, Lan T, Hong W, Dong H, Wei Y
ACS Nano. 2024; 18(36):24650-24681.
PMID: 39185745
PMC: 11394369.
DOI: 10.1021/acsnano.3c10797.
Overcoming Barriers in Glioblastoma-Advances in Drug Delivery Strategies.
Ter Linden E, Abels E, van Solinge T, Neefjes J, Broekman M
Cells. 2024; 13(12.
PMID: 38920629
PMC: 11201826.
DOI: 10.3390/cells13120998.
Parenteral, Non-Intravenous Analgesia in Acute Traumatic Pain-A Narrative Review Based on a Systematic Literature Search.
de Grunt M, de Jong B, Hollmann M, Ridderikhof M, Weenink R
J Clin Med. 2024; 13(9).
PMID: 38731088
PMC: 11084350.
DOI: 10.3390/jcm13092560.
Formulation of Metoclopramide Hydrochloride-Loaded Lipid Carriers by QbD Approach for Combating Nausea: Safety and Bioavailability Evaluation in New Zealand Rabbit.
Baranauskaite J, Aydin M, Uner B, Tas C
AAPS PharmSciTech. 2024; 25(4):73.
PMID: 38575825
DOI: 10.1208/s12249-024-02791-0.
The novel peptide LCGM-10 attenuates metabotropic glutamate receptor 5 activity and demonstrates behavioral effects in animal models.
Malyshev A, Pavshintcev V, Mitkin N, Sukhanova I, Gedzun V, Zlobin A
Front Behav Neurosci. 2024; 18:1333258.
PMID: 38385004
PMC: 10879279.
DOI: 10.3389/fnbeh.2024.1333258.
Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties.
Pandya J, Musyaju S, Modi H, Okada-Rising S, Bailey Z, Scultetus A
J Transl Med. 2024; 22(1):167.
PMID: 38365798
PMC: 10874030.
DOI: 10.1186/s12967-024-04908-2.
Nose-to-Heart Approach: Unveiling an Alternative Route of Acute Treatment.
Papakyriakopoulou P, Valsami G, Kadoglou N
Biomedicines. 2024; 12(1).
PMID: 38255302
PMC: 10813812.
DOI: 10.3390/biomedicines12010198.
Ketamine in Trauma: A Literature Review and Administration Guidelines.
Reede K, Bartholomew R, Nielsen D, Ahmeti M, Zreik K
Cureus. 2023; 15(11):e48099.
PMID: 37920424
PMC: 10620013.
DOI: 10.7759/cureus.48099.
Effectiveness of Intranasal Analgesia in the Emergency Department.
Zanza C, Saglietti F, Giamello J, Savioli G, Biancone D, Balzanelli M
Medicina (Kaunas). 2023; 59(10).
PMID: 37893464
PMC: 10608673.
DOI: 10.3390/medicina59101746.
The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 1-Establishing a Nasal In Vitro Model for Drug Delivery Testing Based on a Novel Cell Line.
Bendas S, Koch E, Nehlsen K, May T, Dietzel A, Reichl S
Pharmaceutics. 2023; 15(9).
PMID: 37765214
PMC: 10536430.
DOI: 10.3390/pharmaceutics15092245.
The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease.
Cherait A, Banks W, Vaudry D
Pharmaceutics. 2023; 15(8).
PMID: 37631246
PMC: 10459484.
DOI: 10.3390/pharmaceutics15082032.
Formulation of Intranasal Mucoadhesive Thermotriggered In Situ Gel Containing Mirtazapine as an Antidepressant Drug.
Ghazwani M, Vasudevan R, Kandasamy G, Manusri N, Devanandan P, Puvvada R
Gels. 2023; 9(6).
PMID: 37367128
PMC: 10297899.
DOI: 10.3390/gels9060457.